We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals to ensure patients are aware of the known side effects of glucagon-like peptide-1 (GLP-1) receptor agonists.
Medicines and Healthcare products Regulatory Agency (MHRA) is highlighting our work training multiple World Health Organisation (WHO) polio laboratories around the world.
The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 October 2024, approved a licence for the medicine donanemab (Kisunla) for use in the early stages of Alzheimer’s disease, following a thorough revi…
The new legislation will introduce clearer and risk-proportionate requirements that improve the safety of medical devices across Great Britain and provide certainty for manufacturers ahead of introducing the wider future reg…
The UK will be the first country in the world to introduce a tailored framework for the regulation of innovative products manufactured at or close to the location where a patient receives care.
Members of the public as well as NHS staff and experts will be invited to share their experiences, views and ideas for fixing the NHS.
Infected Blood Compensation Authority's newsletter that was circulated on 17 October 2024
Ambassador to work with employers to help women experiencing menopause symptoms to stay in work and progress in their careers.
The government will fund research into wearable technology, virtual reality and artificial intelligence in a bid to support people with drug addictions.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive …
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis (PBC).
The UK chief medical officers and NHS England National Medical Director have given advice to help doctors wanting to take part in the assisted dying debate.
A new strategy is being published to radically cut the number of single-use medical devices in the health service.
Patient safety at heart of government’s plans for healthcare reform as Health and Social Care Secretary orders action to improve regulator performance.
Collaboration announced at International Investment Summit, meeting the PM's ambitions to catalyse investment in the UK and proving the UK is open for business.
Infected Blood Compensation Authority's newsletter that was circulated on 17 September 2024.
Infected Blood Compensation Authority's newsletter that was circulated on 10 October 2024.
Scientists at VDEC use ‘organ-on-a-chip’ models to study infections and immune responses, aiming to improve vaccine testing and reduce reliance on animal research.
The extension of the UN Disability Convention will protect the rights of over three thousand disabled people living in Bermuda.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).